Outsourced Pharma App Notes & Case Studies

31. Accelerating Technology Transfer Of A Drug Product 9/9/2026

    See how structured testing can reduce transfer risk, confirm scalability and reuse strategies, as well as how to improve process robustness and deliver meaningful savings on chemicals and consumables.

32. From Plasmids To Cell-Free DNA For Advanced Gene Therapies 6/25/2026

    Switching from bacterial plasmids to cell-free circular ssDNA boosts gene-editing safety and precision, reduces toxicity, enables up to 75% knock-in efficiency, and improves primary cell viability.

33. Comparing Process Development Approaches For Recombinant Proteins 2/26/2026

    Explore how adding a traceless tag enables streamlined affinity purification for recombinant proteins, and how this approach compares with a conventional process in development time, recovery, and purity.

34. Fast-Tracking NDA Approval For A Novel Compound To Treat Infections 6/2/2026

    Strategic tech transfer and scalable manufacturing enabled rapid NDA approval, delivering registration batches and accelerating commercialization of a novel therapy for drug-resistant infections.

35. 12.5x Titer Boost Accelerates CAR-T Program To IND Filing 3/4/2026

    Plasmid engineering and process development boosted viral titer 12.5×, eliminating manufacturing bottlenecks and enabling an on‑time regulatory submission for the cell therapy program.

36. Virus Retention Performance Under Diverse Processing Conditions 11/14/2025

    Virus filtration is robust across a wide range of process parameters, including high protein concentration and flow decay. Discover how retention relies on size exclusion to simplify risk assessment.

37. A Unified Development Blueprint For Accelerating Timelines: DNA To DS Bulk Fill In 8.5 months 8/4/2026

    Learn how early integration of cell line engineering, process development, and analytics compressed a complex antibody program from DNA to drug substance bulk fill in just 8.5 months.

38. Providing Solutions In Titer, Host Cell Protein, And Scalability 4/23/2026

    By leveraging expertise across a global network and executing a streamlined, rapid technology transfer, see how we were able to enable a highly data-driven approach to clone selection and process optimization.

39. Digitized Solutions To Increase Visibility And Streamline Communication Between A PSP And Manufacturer 2/18/2026

    When email-based escalation management creates compliance and visibility gaps, a centralized digital solution helps manufacturer and PSP teams act faster and with greater accountability.

40. Accelerating A Complex Molecule From CLD To cGMP In 12 Months 11/19/2025

    Learn how to mitigate technical risk, implement parallel process development, and design custom purification strategies for highly sensitive novel modalities to accelerate to cGMP material.